Revolution Medicines Inc. Common Stock vs State Street PDR S&P Retail ETF — how do they compare? Revolution Medicines Inc. Common Stock trades at $189.69 (market cap $40.32B), while State Street PDR S&P Retail ETF trades at $84.19 (market cap $389.66M). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 103.5× State Street PDR S&P Retail ETF's market cap, and Revolution Medicines Inc. Common Stock is trading nearer its 52-week high, State Street PDR S&P Retail ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Revolution Medicines Inc. Common Stock for 0 Days and State Street PDR S&P Retail ETF for 45 Days on average.
| RVMD | XRT | |
|---|---|---|
Market Cap | $40.32B | $389.66M |
Volume | 4,855,734 | 4,275,820 |
Sector | Health | Broad Market / Factor |
52-Week High | $221.15 | $92.35 |
52-Week Low | $47.50 | $77.28 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $37.02B | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
XRT trades at $84.09, up 1.42% with a bullish technical signal despite mixed moving averages and oscillators. The ETF faces headwinds from higher interest rates and inflation impacting consumer sentiment, with Seeking Alpha noting underperformance against IVV YTD. Recent retail sales data shows volatility, with August rebounding 1.2% after July's unexpected 0.6% decline. The holiday season projection of $1 trillion in sales provides potential upside catalyst.
The retail ETF's outlook remains challenged by macroeconomic pressures, though selective consumer spending and potential Fed easing could support recovery. Key risks include persistent inflation and interest rate sensitivity, while technical support at $81-83 levels provides near-term stability. Analyst sentiment appears cautious given the unsupportive macro environment heading into 2027.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →